Home » Topics » Conferences

Conferences
RSS

New class of topo I inhibitors designed for oral administration

May 9, 1997

Natural cancer immunotherapeutic discovered by Yonsei University researchers

May 9, 1997

Novel EGF receptor TK inhibitor described by Mitsubishi

May 9, 1997

BM-92.0700: a promising anticancer clinical candidate

May 9, 1997

ONYX-015 demonstrates in vitro and in vivo efficacy

May 9, 1997

Preclinical data for ZD-1839, an EGF tyrosine kinase inhibitor

May 9, 1997

Cinchonine shown to reverse multidrug resistance

May 9, 1997

Preclinical and preliminary clinical data reported for LU-103793

May 9, 1997

Alniditan more effective than sumatriptan in animal model of migraine

May 7, 1997

Riboflavin shows promise for migraine prophylaxis

May 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...